CHICAGO (AP) — CHICAGO (AP) — Exelon Corp. (EXC) on Wednesday reported fourth-quarter earnings of $647 million. The results exceeded Wall Street expectations. The average estimate of five analysts ...

New York Times reporter Jeremy Peters and Princeton University Professor Eddie Glaude join Chris Jansing to discuss President ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...

Prescription drugs can be administered in various ways. This includes oral (by mouth), enteral (into the gastrointestinal tract), mucosal (through a mucus membrane), and percutaneous (through the skin ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease and caregivers.

The Alzheimer's medications currently approved by the FDA come in two groups: Cholinesterase inhibitors (Aricept, Razadyne, Exelon): One major cause of Alzheimer's symptoms is decreased production ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

Barclays analyst Nicholas Campanella maintained a Buy rating on Exelon (EXC – Research Report) today and set a price target of $42.00. The company’s shares closed yesterday at $40.44.